Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models

被引：0
|
作者：
Shu Shimada
Yoshimitsu Akiyama
Kaoru Mogushi
Mari Ishigami-Yuasa
Hiroyuki Kagechika
Hiromi Nagasaki
Hiroshi Fukamachi
Yasuhito Yuasa
Shinji Tanaka
机构：
[1] Tokyo Medical and Dental University,Department of Molecular Oncology, Graduate School of Medicine
[2] Juntendo University School of Medicine,Center for Genomic and Regenerative Medicine
[3] Tokyo Medical and Dental University,Chemical Biology Screening Center, and Department of Organic and Medicinal Chemistry, Institute of Biomaterials and Bioengineering
[4] Tokyo Medical and Dental University,Department of Hepato
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：972 / 984
页数：12
相关论文
共 50 条
  • [41] Identification of signal transduction pathway in PDX-derived diffuse-type gastric tumor-initiating cells
    Fukamachi, Hiroshi
    Nishikawaji, Taketo
    Shimada, Shu
    Akiyama, Yoshimitsu
    Yuasa, Yasuhito
    Tuchiya, Kiichiro
    Tanaka, Shinji
    CANCER SCIENCE, 2018, 109 : 880 - 880
  • [42] The master regulators of causal networks in intestinal- and diffuse-type gastric cancer
    Tanabe, Shihori
    Quader, Sabina
    Ono, Ryuichi
    Cabral, Horacio
    Aoyagi, Kazuhiko
    Hirose, Akihiko
    Yokozaki, Hiroshi
    Sasaki, Hiroki
    CANCER SCIENCE, 2024, 115 : 1777 - 1777
  • [43] Genomic features of Helicobacter pylori-naive diffuse-type gastric cancer
    Namikawa, Ken
    Tanaka, Norio
    Ota, Yuki
    Takamatsu, Manabu
    Kosugi, Mayuko
    Tokai, Yoshitaka
    Yoshimizu, Shoichi
    Horiuchi, Yusuke
    Ishiyama, Akiyoshi
    Yoshio, Toshiyuki
    Hirasawa, Toshiaki
    Amino, Sayuri
    Furuya, Rie
    Gotoh, Osamu
    Kaneyasu, Tomoko
    Nakayama, Izuma
    Imamura, Yu
    Noda, Tetsuo
    Fujisaki, Junko
    Mori, Seiichi
    JOURNAL OF PATHOLOGY, 2022, 258 (03): : 300 - 311
  • [44] GASTRIC PRE-CANCEROUS LESIONS AND DIFFUSE-TYPE GASTRIC CANCER: A META-ANALYSIS
    Wang, John E.
    Huang, Robert J.
    GASTROINTESTINAL ENDOSCOPY, 2021, 93 (06) : AB336 - AB337
  • [45] Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer
    Ascaño, JJ
    Frierson, H
    Moskaluk, CA
    Harper, JC
    Roviello, F
    Jackson, CE
    El-Rifai, W
    Vindigni, C
    Tosi, P
    Powell, SM
    MODERN PATHOLOGY, 2001, 14 (10) : 942 - 949
  • [46] Whole-genome analysis of a mouse model of diffuse-type gastric cancer
    Zhang, Menghua
    Sugita, Itsuki
    Komura, Daisuke
    Katoh, Hiroto
    Ishikawa, Shumpei
    CANCER SCIENCE, 2021, 112 : 606 - 606
  • [47] Differences in genomic instability between intestinal- and diffuse-type gastric cancer
    Vauhkonen M.
    Vauhkonen H.
    Sajantila A.
    Sipponen P.
    Gastric Cancer, 2005, 8 (4) : 238 - 244
  • [48] Evolutionary History of the Risk of SNPs for Diffuse-Type Gastric Cancer in the Japanese Population
    Iwasaki, Risa L.
    Ishiya, Koji
    Kanzawa-Kiriyama, Hideaki
    Kawai, Yosuke
    Gojobori, Jun
    Satta, Yoko
    GENES, 2020, 11 (07) : 1 - 19
  • [49] EMMPRIN in extracellular vesicles from peritoneal mesothelial cells stimulates the invasion activity of diffuse-type gastric cancer cells
    Sugimoto, Atsushi
    Okuno, Tomohisa
    Miki, Yuichiro
    Tsujio, Gen
    Sera, Tomohiro
    Yamamoto, Yurie
    Kushiyama, Shuhei
    Nishimura, Sadaaki
    Kuroda, Kenji
    Togano, Shingo
    Maruo, Koji
    Kasashima, Hiroaki
    Ohira, Masaichi
    Yashiro, Masakazu
    CANCER LETTERS, 2021, 521 : 169 - 177
  • [50] Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers
    Sasaki, Mariko
    Chiwaki, Fumiko
    Kohno, Takashi
    Sasaki, Hiroki
    Ogiwara, Hideaki
    CANCER SCIENCE, 2022, 113 : 1759 - 1759
12345